← Back to Search

Blood collection for Blood Clot (NOVEL-3 Trial)

N/A
Waitlist Available
Led By Judith Kirstein
Research Sponsored by LumiraDx UK Limited
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects must be >18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights

NOVEL-3 Trial Summary

This trial looked at whether the results of two point-of-care tests for blood clotting and inflammation were comparable to those of reference laboratory tests.

Who is the study for?
This trial is for adults over 18 who have symptoms of infection, inflammation, or blood clots and are seeking medical attention. They must be willing to consent and comply with study procedures. Excluded are those with skin conditions preventing blood draws, on recent anticoagulants or experimental drugs, critically ill, or in end-of-life care.Check my eligibility
What is being tested?
The trial tests the accuracy of LumiraDx Point of Care D-Dimer and CRP Tests using fingerstick and venepuncture methods against a reference analyzer. It aims to see if these quick bedside tests agree with standard lab results in various clinical conditions.See study design
What are the potential side effects?
Since this trial involves common blood collection methods like fingersticks and venepuncture rather than drug interventions, side effects may include minor pain at the puncture site, bruising, bleeding, or fainting during the blood draw.

NOVEL-3 Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am older than 18 years.

NOVEL-3 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Assessment of sample matrix comparison

NOVEL-3 Trial Design

1Treatment groups
Experimental Treatment
Group I: Blood collectionExperimental Treatment2 Interventions
Venepuncture and fingerstick to obtain venous blood and capillary blood respectively
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Venepuncture
2018
N/A
~790
Fingerstick
2021
N/A
~420

Find a Location

Who is running the clinical trial?

LumiraDx UK LimitedLead Sponsor
15 Previous Clinical Trials
34,290 Total Patients Enrolled
Judith KirsteinPrincipal InvestigatorRancho Paseo Medical Group
William SimonPrincipal InvestigatorNew Medical Healthcare
2 Previous Clinical Trials
2,153 Total Patients Enrolled

Media Library

Blood collection Clinical Trial Eligibility Overview. Trial Name: NCT04375982 — N/A
Blood Clot Research Study Groups: Blood collection
Blood Clot Clinical Trial 2023: Blood collection Highlights & Side Effects. Trial Name: NCT04375982 — N/A
Blood collection 2023 Treatment Timeline for Medical Study. Trial Name: NCT04375982 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

In how many different medical facilities is this clinical trial taking place?

"Currently, there are 4 clinical trial sites running this study: Rancho Paseo Medical Group in Banning, Centura Health Physician Group in Northglenn, New Medical Healthcare in Wichita, and 4 other locations."

Answered by AI

Is this a closed or open clinical trial?

"No, this particular clinical trial isn't looking for patients right now. It was first made public on April 20th, 2020 and the most recent update was on August 16th, 2022. That being said, there are 626 other trials that are currently enrolling patients."

Answered by AI

Who else is applying?

What site did they apply to?
Centura Health Physician Group
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests
2020. "Evaluation of the LumiraDx Point of Care D-Dimer and CRP Tests". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04375982.
~40 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top